Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.25.3
Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2023 $ 3 $ 15 $ 717,396 $ (694,870) $ (20,957) $ 1,587
Balance (in shares) at Dec. 31, 2023 3,427,138 15,093,053        
Stock-based compensation expense     16,429     16,429
Issuance of common stock related to equity plans (in shares)   547,196        
Issuance of common stock under ESPP     51     51
Issuance of common stock under ESPP (in shares)   29,844        
Issuance of common stock for equity offering, net   $ 8 17,470     17,478
Issuance of common stock for equity offering, net (in shares)   8,006,058        
Issuance of common stock for at-the-market offering, net   $ 2 3,392     3,394
Issuance of common stock for at-the-market offering, net (in shares)   1,797,857        
Common shares issued for dividend on partner company's convertible preferred shares     114     114
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   64,747        
Common shares issued for exchange of partner company's convertible preferred shares   $ 3 3,406     3,409
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345        
Warrants issued in conjunction with exchange of partner company's convertible preferred shares     (341)     (341)
Preferred A dividends declared and paid     (4,016)     (4,016)
Partner companies' offerings, net     28,852     28,852
Partner company's at-the-market offering, net     3,657     3,657
Issuance of common stock under partner company's ESPP     (257)     (257)
Partner company's dividends declared and paid     (528)     (528)
Exercise of warrants     30     30
Exercise of warrants (in shares)   17,500        
Exercise of partner company options and warrants for cash, net     (9,434)     (9,434)
Non-controlling interest in partner companies     (42,369)   42,369  
Net loss attributable to non-controlling interest         (55,308) (55,308)
Net income (loss) attributable to common stockholders       (39,232)   (39,232)
Warrant issued in conjunction with debt     1,313     1,313
Balance at Sep. 30, 2024 $ 3 $ 28 755,229 (734,102) (33,896) (12,738)
Balance (in shares) at Sep. 30, 2024 3,427,138 27,584,600        
Balance at Jun. 30, 2024 $ 3 $ 23 739,086 (721,235) (32,475) (14,598)
Balance (in shares) at Jun. 30, 2024 3,427,138 22,587,038        
Stock-based compensation expense     6,573     6,573
Issuance of common stock related to equity plans (in shares)   51,435        
Issuance of common stock for equity offering, net   $ 5 7,355     7,360
Issuance of common stock for equity offering, net (in shares)   4,702,753        
Issuance of common stock for at-the-market offering, net     568     568
Issuance of common stock for at-the-market offering, net (in shares)   243,374        
Partner companies' offerings, net     10,850     10,850
Partner company's at-the-market offering, net     1,878     1,878
Issuance of common stock under partner company's ESPP     124     124
Partner company's dividends declared and paid     (176)     (176)
Partner companies' proceeds from options     63     63
Non-controlling interest in partner companies     (12,406)   12,406  
Net loss attributable to non-controlling interest         (13,827) (13,827)
Net income (loss) attributable to common stockholders       (12,867)   (12,867)
Warrant issued in conjunction with debt     1,314     1,314
Balance at Sep. 30, 2024 $ 3 $ 28 755,229 (734,102) (33,896) (12,738)
Balance (in shares) at Sep. 30, 2024 3,427,138 27,584,600        
Balance at Dec. 31, 2024 $ 3 $ 28 763,573 (740,867) (24,381) (1,644)
Balance (in shares) at Dec. 31, 2024 3,427,138 27,908,839        
Stock-based compensation expense     26,280     26,280
Issuance of common stock related to equity plans   $ 1 (1)      
Issuance of common stock related to equity plans (in shares)   1,278,005        
Issuance of common stock under ESPP     43     43
Issuance of common stock under ESPP (in shares)   35,546        
Redemption of partner company preferred shares     (265)     (265)
Issuance of common stock for at-the-market offering, net   $ 1 1,008     1,009
Issuance of common stock for at-the-market offering, net (in shares)   539,563        
Partner company's warrant exercises     61,238     61,238
Partner company's at-the-market offering, net     13,631     13,631
Issuance of common stock under partner company's ESPP     217     217
Partner company's dividends declared and paid     (498)     (498)
Partner company's exercise of options for cash     343     343
Exercise of warrants   $ 1 2,279     2,280
Exercise of warrants (in shares)   1,355,582        
Shares Withheld Related To Net Settlement Of Warrants   (112,365)        
Deconsolidation of subsidiary non-controlling interests         (9,931) (9,931)
Non-controlling interest in partner companies     (81,905)   81,905  
Net loss attributable to non-controlling interest         (38,270) (38,270)
Net income (loss) attributable to common stockholders       10,752   10,752
Balance at Sep. 30, 2025 $ 3 $ 31 785,943 (730,115) 9,323 65,185
Balance (in shares) at Sep. 30, 2025 3,427,138 31,005,170        
Balance at Jun. 30, 2025 $ 3 $ 30 779,856 (735,965) (6,541) 37,383
Balance (in shares) at Jun. 30, 2025 3,427,138 29,752,775        
Stock-based compensation expense     3,197     3,197
Issuance of common stock related to equity plans (in shares)   106,378        
Partner company's warrant exercises     7,144     7,144
Partner company's at-the-market offering, net     6,891     6,891
Issuance of common stock under partner company's ESPP     118     118
Partner company's dividends declared and paid     (166)     (166)
Partner company's exercise of options for cash     103     103
Exercise of warrants   $ 1 1,687     1,688
Exercise of warrants (in shares)   1,258,382        
Shares Withheld Related To Net Settlement Of Warrants   (112,365)        
Non-controlling interest in partner companies     (12,887)   12,887  
Net loss attributable to non-controlling interest         2,977 2,977
Net income (loss) attributable to common stockholders       5,850   5,850
Balance at Sep. 30, 2025 $ 3 $ 31 $ 785,943 $ (730,115) $ 9,323 $ 65,185
Balance (in shares) at Sep. 30, 2025 3,427,138 31,005,170